Jacob Appelbaum

3.4k total citations · 1 hit paper
41 papers, 2.1k citations indexed

About

Jacob Appelbaum is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jacob Appelbaum has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jacob Appelbaum's work include Acute Myeloid Leukemia Research (12 papers), CAR-T cell therapy research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jacob Appelbaum is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), CAR-T cell therapy research (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Jacob Appelbaum collaborates with scholars based in United States, Spain and Israel. Jacob Appelbaum's co-authors include Alanna Schepartz, William Clarkson, J. Alex Halderman, Seth David Schoen, Joseph A. Calandrino, William Paúl, Ariel J. Feldman, Nadia Heninger, Edward W. Felten and Alfred Singer and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jacob Appelbaum

33 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lest we remember

2009 513 citations J. Alex Halderman, Seth David Schoen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob Appelbaum United States	16	684	588	391	381	318	41	2.1k
Kenji Kono Japan	34	258 0.4×	1.7k 2.8×	485 1.2×	401 1.1×	145 0.5×	151	3.4k
Xiaoying Jia United States	26	284 0.4×	1.3k 2.2×	314 0.8×	386 1.0×	54 0.2×	83	2.8k
Michael D. Bond United States	30	566 0.8×	596 1.0×	114 0.3×	368 1.0×	236 0.7×	88	2.3k
Youhui Zhang China	28	283 0.4×	522 0.9×	456 1.2×	102 0.3×	28 0.1×	123	2.3k
Michael B. Feldman United States	21	144 0.2×	782 1.3×	417 1.1×	95 0.2×	68 0.2×	85	1.9k
Huili Chen United States	15	413 0.6×	176 0.3×	92 0.2×	84 0.2×	114 0.4×	44	885
Adam Kieżun United States	23	473 0.7×	1.1k 1.9×	423 1.1×	845 2.2×	307 1.0×	43	3.2k
Luigi Cerulo Italy	30	431 0.6×	444 0.8×	112 0.3×	1.4k 3.7×	239 0.8×	80	2.3k
Junning Liu China	18	498 0.7×	177 0.3×	81 0.2×	687 1.8×	68 0.2×	54	1.9k

Countries citing papers authored by Jacob Appelbaum

Since Specialization

Citations

This map shows the geographic impact of Jacob Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Appelbaum more than expected).

Fields of papers citing papers by Jacob Appelbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Appelbaum. The network helps show where Jacob Appelbaum may publish in the future.

Co-authorship network of co-authors of Jacob Appelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Appelbaum. A scholar is included among the top collaborators of Jacob Appelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Appelbaum. Jacob Appelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raychaudhuri, Suravi, Kevin K. Chung, Jeffrey S. McLean, et al.. (2025). Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples. npj Biofilms and Microbiomes. 11(1). 88–88.

Abrams, Hannah R., Helene Starks, Mary‐Elizabeth M. Percival, et al.. (2025). Logistical and Non-Medical Barriers to Hematopoietic Cell Transplantation (HCT) and Chimeric Antigen Receptor T-Cell (CAR T) Therapy: A Survey of National Comprehensive Cancer Network (NCCN) Centers. Transplantation and Cellular Therapy. 31(2). S51–S52. 1 indexed citations

Appelbaum, Jacob, et al.. (2024). Loss of 5q Drives Evolution to Aneuploidy in an iPSC Model of Complex Karyotype AML. Blood. 144(Supplement 1). 629–629.

Appelbaum, Jacob, Kathryn Russell, Xueyan Chen, et al.. (2024). Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6517–6517.

Raychaudhuri, Suravi, Megan Othus, Mary‐Elizabeth M. Percival, et al.. (2024). Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203.. Journal of Clinical Oncology. 42(16_suppl). 6529–6529.

Milano, Filippo, Brenda M. Sandmaier, Mary‐Elizabeth M. Percival, et al.. (2024). CLAG-M or FLAG-Ida Followed Immediately By Allogeneic Hematopoietic Cell Transplantation for Adults with Relapsed/Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm. Blood. 144(Supplement 1). 265–265.

Othus, Megan, Anna B. Halpern, Jacob Appelbaum, et al.. (2023). Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents. Leukemia & lymphoma. 64(5). 990–996. 1 indexed citations

Othus, Megan, Mohamed L. Sorror, Anna B. Halpern, et al.. (2022). Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms. Leukemia. 37(1). 231–234. 4 indexed citations

Godwin, Colin D., Eduardo Rodríguez‐Arbolí, Megan Othus, et al.. (2022). Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms. Cancers. 14(12). 2934–2934. 2 indexed citations

10.

Othus, Megan, Katie W. Russell, Anna B. Halpern, et al.. (2022). Time to Count Recovery after Post-Remission Chemotherapy in AML Patients. Blood. 140(Supplement 1). 6080–6081.

11.

Appelbaum, Jacob, Donald M. Arnold, John G. Kelton, et al.. (2021). SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances. 6(7). 2250–2253. 13 indexed citations

12.

Acharya, Utkarsh, Tejaswini Dhawale, Seongseok Yun, et al.. (2019). Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy. Expert Review of Hematology. 12(3). 195–205. 64 indexed citations

13.

Appelbaum, Jacob, David J. Wells, Joseph B. Hiatt, et al.. (2018). Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. Journal for ImmunoTherapy of Cancer. 6(1). 82–82. 41 indexed citations

14.

Craig, Cody J., Rebecca L. Pongratz, Jacob Appelbaum, et al.. (2013). A β-Peptide Agonist of the GLP-1 Receptor, a Class B GPCR. Organic Letters. 15(20). 5318–5321. 32 indexed citations

15.

Appelbaum, Jacob, et al.. (2012). OONI : Open Observatory of Network Interference. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(4). 249–51. 65 indexed citations

16.

Appelbaum, Jacob, et al.. (2012). Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the Cytoplasm. Chemistry & Biology. 19(7). 819–830. 144 indexed citations

17.

Scheck, Rebecca A., et al.. (2012). Bipartite Tetracysteine Display Reveals Allosteric Control of Ligand-Specific EGFR Activation. ACS Chemical Biology. 7(8). 1367–1376. 45 indexed citations

18.

Appelbaum, Jacob, et al.. (2011). Visualizing protein partnerships in living cells and organisms. Current Opinion in Chemical Biology. 15(6). 781–788. 33 indexed citations

19.

Halderman, J. Alex, Seth David Schoen, Nadia Heninger, et al.. (2008). Lest we remember: cold boot attacks on encryption keys. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 43(5). 45–60. 280 indexed citations

20.

Park, Jung‐Hyun, Qing Yu, Batu Erman, et al.. (2004). Suppression of IL7Rα Transcription by IL-7 and Other Prosurvival Cytokines. Immunity. 21(2). 289–302. 386 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact